Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effects of Ocrelizumab on the Circulating Metabolome in Multiple Sclerosis (MS)

NCT03873389 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03873389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effects of Ocrelizumab on the Circulating Metabolome in Multiple Sclerosis (MS)
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Completed
Start date
June 12, 2019
Completion date
December 5, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis